ArticleCytotherapy2021

Glucuronoxylomannan in the Cryptococcus species capsule as a target for Chimeric Antigen Receptor T-cell therapy.

Thiago Aparecido da Silva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.